(S (NP (PRP We)) (VP (VBD used) (NP (NN redescription) (NN mining)) (S (VP (TO to) (VP (VB find) (NP (NP (JJ interpretable) (NNS rules)) (VP (VBG revealing) (NP (NP (NNS associations)) (PP (IN between) (NP (NP (DT those) (NNS determinants)) (SBAR (WHNP (WDT that)) (S (VP (VBP provide) (NP (NP (NNS insights)) (PP (IN about) (NP (NP (NP (DT the) (NNP Alzheimer) (POS 's)) (NN disease)) (PRN (-LRB- -LRB-) (NP (NNP AD)) (-RRB- -RRB-))))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD extended) (NP (DT the) (NNP CLUS-RM) (NN redescription) (NN mining) (NN algorithm)) (PP (TO to) (NP (NP (DT a) (JJ constraint-based) (NN redescription) (NN mining) (PRN (-LRB- -LRB-) (NNP CBRM) (-RRB- -RRB-)) (NN setting)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ enables) (NP (NP (JJ several) (NNS modes)) (PP (IN of) (NP (NP (JJ targeted) (NN exploration)) (PP (IN of) (NP (JJ specific) (, ,) (JJ user-constrained) (NNS associations)))))))))))) (. .))
(S (NP (NN Redescription) (NN mining)) (VP (VBD enabled) (S (VP (VBG finding) (NP (NP (JJ specific) (NNS constructs)) (PP (IN of) (NP (ADJP (JJ clinical) (CC and) (JJ biological)) (NNS attributes))) (SBAR (WHNP (IN that)) (S (VP (VBP describe) (NP (NP (JJ many) (NNS groups)) (PP (IN of) (NP (NP (NNS subjects)) (PP (IN of) (NP (JJ different) (NX (NX (NN size)) (, ,) (NX (NN homogeneity)) (CC and) (NX (NX (NNS levels)) (PP (IN of) (NP (JJ cognitive) (NN impairment))))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD confirmed) (NP (DT some) (ADJP (RB previously) (VBN known)) (NNS findings))) (. .))
(S (ADVP (RB However)) (, ,) (PP (IN in) (NP (DT some) (NNS instances))) (, ,) (PP (IN as) (PP (IN with) (NP (NP (DT the) (NNS attributes)) (: :) (NP (NP (NN testosterone)) (, ,) (NP (NP (DT the) (VBG imaging) (JJ attribute)) (NP (NP (NNP Spatial) (NNP Pattern)) (PP (IN of) (NP (NNP Abnormalities))) (PP (IN for) (NP (NP (NNP Recognition)) (PP (IN of) (NP (NNP Early) (NNP AD))))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN leptin) (CC and) (NN angiopoietin-2))) (PP (IN in) (NP (NN plasma)))))))) (, ,) (NP (PRP we)) (VP (VP (VBD corroborated) (NP (ADJP (RB previously) (JJ debatable)) (NNS findings))) (CC or) (VP (VBN provided) (NP (NP (JJ additional) (NN information)) (PP (IN about) (NP (NP (DT these) (NNS variables)) (CC and) (NP (NP (PRP$ their) (NN association)) (PP (IN with) (NP (NNP AD) (NN pathogenesis))))))))) (. .))
(S (S (VP (VBG Applying) (NP (NN redescription) (NN mining)) (PP (IN on) (NP (NNP ADNI) (NNS data))))) (VP (VBD resulted) (PP (IN with) (NP (NP (DT the) (NN discovery)) (PP (IN of) (NP (NP (CD one) (ADJP (RB largely) (JJ unknown)) (NN attribute)) (: :) (NP (NP (DT the) (JJ Pregnancy-Associated) (NNP Protein-A)) (PRN (-LRB- -LRB-) (NP (NNP PAPP-A)) (-RRB- -RRB-)) (, ,) (SBAR (WHNP (WDT which)) (S (NP (PRP we)) (VP (VBD found) (S (ADJP (RB highly) (VBN associated) (PP (IN with) (NP (NP (JJ cognitive) (NN impairment)) (PP (IN in) (NP (NNP AD)))))))))))))))) (. .))
(S (NP (NP (ADJP (RB Statistically) (JJ significant)) (NNS correlations)) (PRN (-LRB- -LRB-) (NP (NP (JJ p)) (NNP <) (NNP =) (NP (CD 0.01))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN found) (PP (IN between) (NP (NP (NNP PAPP-A)) (CC and) (NP (JJ various) (JJ different) (JJ clinical) (NNS tests)))))) (. .))
(S (NP (NP (DT The) (JJ high) (NN importance)) (PP (IN of) (NP (DT this) (NN finding)))) (VP (VBZ lies) (PP (IN in) (NP (DT the) (NN fact) (SBAR (IN that) (S (NP (NNP PAPP-A)) (VP (VBZ is) (NP (NP (DT a) (NN metalloproteinase)) (, ,) (VP (VBN known) (S (VP (TO to) (VP (VB cleave) (NP (JJ insulin-like) (NN growth) (NN factor) (VBG binding) (NNS proteins))))))))))))) (. .))
(S (ADVP (RB Therefore)) (, ,) (NP (JJ further) (NNS studies)) (VP (MD should) (VP (VB investigate) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NNP PAPP-A))) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNP AD)))))) (ADVP (JJR more) (RB thoroughly)))) (. .))
